Bayer AG (BAYN) Given a €120.00 Price Target at Independent Research GmbH
Bayer AG (FRA:BAYN) received a €120.00 ($141.18) price objective from Independent Research GmbH in a research note issued on Wednesday. The brokerage currently has a “neutral” rating on the healthcare company’s stock.
Several other research firms also recently commented on BAYN. Sanford C. Bernstein set a €128.00 ($150.59) price objective on Bayer AG and gave the company a “buy” rating in a report on Tuesday, June 6th. Commerzbank Ag set a €126.00 ($148.24) target price on Bayer AG and gave the stock a “buy” rating in a report on Wednesday, June 7th. UBS AG set a €125.00 ($147.06) price target on shares of Bayer AG and gave the company a “buy” rating in a research report on Wednesday, June 7th. Baader Bank set a €120.00 ($141.18) price target on shares of Bayer AG and gave the company a “neutral” rating in a research note on Friday, June 9th. Finally, Bank of America Corporation set a €140.00 ($164.71) price objective on shares of Bayer AG and gave the stock a “buy” rating in a report on Monday, June 12th. Seven research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. Bayer AG currently has an average rating of “Buy” and a consensus target price of €121.45 ($142.89).
Bayer AG (FRA BAYN) traded up 2.359% during mid-day trading on Wednesday, hitting €118.225. 6,839 shares of the stock were exchanged. The company has a market capitalization of €103.10 billion and a PE ratio of 20.451. Bayer AG has a 1-year low of €85.72 and a 1-year high of €123.83. The stock has a 50 day moving average price of €109.86 and a 200 day moving average price of €111.81.
Bayer AG Company Profile
Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.